Company / Cash per Share
Haemonetics Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.04
FY2025
5-year range
$3.54 / $6.04
FY2021-FY2025
Trend
+70.4%
vs FY2024
Sector context
#42 of 150
Health Care
What the data says
At $6.04, Haemonetics's cash per share ranks #42 of 150 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $2.23 in FY2016 to $6.04 in FY2025.
Based on SEC 10-K filings.
6.04 in FY2025 with a 5-year CAGR of +17.7%.
Improved from $5.53 to $6.04 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Sector benchmark
#42 of 150 in Health CareTop 28% of 150This company $6.04 Sector average $27.11
▼
-77.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 70.4% year-over-year.
- Ranks #42 out of 150 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.04 | +70.4% |
| FY2024 | $3.54 | -36.0% |
| FY2023 | $5.53 | +9.7% |
| FY2022 | $5.05 | +34.8% |
| FY2021 | $3.74 | +39.9% |
| FY2020 | $2.68 | -18.1% |
| FY2019 | $3.27 | -5.2% |
| FY2018 | $3.45 | +25.8% |
| FY2017 | $2.74 | +23.0% |
| FY2016 | $2.23 | -27.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026